000 01282 a2200385 4500
005 20250517115237.0
264 0 _c20170713
008 201707s 0 0 eng d
022 _a1548-4475
024 7 _a10.1038/laban.1106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlankenship-Paris, Terry L
245 0 0 _aEvaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice.
_h[electronic resource]
260 _bLab animal
_cSep 2016
300 _a370-9 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAnalgesia
_xveterinary
650 0 4 _aAnalgesics, Opioid
_xblood
650 0 4 _aAnimals
650 0 4 _aBuprenorphine
_xblood
650 0 4 _aFeeding Behavior
_xdrug effects
650 0 4 _aHydrogels
650 0 4 _aHyperlipidemias
_xchemically induced
650 0 4 _aMale
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aPoloxamer
700 1 _aDutton, John W
700 1 _aGoulding, David R
700 1 _aMcGee, Christopher A
700 1 _aKissling, Grace E
700 1 _aMyers, Page H
773 0 _tLab animal
_gvol. 45
_gno. 10
_gp. 370-9
856 4 0 _uhttps://doi.org/10.1038/laban.1106
_zAvailable from publisher's website
999 _c26441128
_d26441128